Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation.
<h4>Background</h4>Transketolase-like 1 (TKTL1) induces glucose degradation through anaerobic pathways, even in presence of oxygen, favoring the malignant aerobic glycolytic phenotype characteristic of tumor cells. As TKTL1 appears to be a valid biomarker for cancer prognosis, the aim of...
Main Authors: | Santiago Diaz-Moralli, Miriam Tarrado-Castellarnau, Cristina Alenda, Antoni Castells, Marta Cascante |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21980427/pdf/?tool=EBI |
Similar Items
-
Glyceraldehyde-3-phosphate dehydrogenase is overexpressed in colorectal cancer onset
by: Míriam Tarrado-Castellarnau, et al.
Published: (2017-06-01) -
Diphenyl urea derivatives as inhibitors of transketolase: a structure-based virtual screening.
by: Cristian Obiol-Pardo, et al.
Published: (2012-01-01) -
A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.
by: Stefan Schneider, et al.
Published: (2012-01-01) -
Glutamine Modulates Expression and Function of Glucose 6-Phosphate Dehydrogenase via NRF2 in Colon Cancer Cells
by: Ibrahim H. Polat, et al.
Published: (2021-08-01) -
Natural evolution and engineering of transketolase
by: Costelloe, S. J.
Published: (2006)